General Information of the Compound
| Compound ID |
CP0066112
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
CLOPIDOGREL
Show/Hide
|
||||||||||||||||||
| Synonyms |
(+)-(S)-Clopidogrel
(+)-Clopidogrel
(S)-Clopidogrel
113665-84-2
A74586SNO7
CHEBI:37941
CLOPIDOGREL SULFATE
CPD000550475
Clopidogrel
Clopidogrel (TN)
Clopidogrel (captisol-enabled)
Clopidogrel (captisol-enabled), The Medicines Co
Clopidogrel (captisol-enabled, cardiovascular disease), Cydex
Clopidogrel (captisol-enabled, cardiovascular disease), Prism Pharmaceuticals
Clopidogrel Acino
Clopidogrel BMS
Clopidogrel Hexal
Clopidogrel [INN:BAN]
Clopidogrelum
GKTWGGQPFAXNFI-HNNXBMFYSA-N
HSDB 7430
PM-103
Plavix
Plavix (TN)
SR-25990C
Thrombo
UNII-A74586SNO7
Zyllt
clopidogrel
methyl (2S)-(2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)ethanoate
methyl (2S)-2-(2-chlorophenyl)-2-{4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}acetate
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C16H16ClNO2S
|
||||||||||||||||||
| Molecular Weight |
321.829
|
||||||||||||||||||
| Canonical SMILES |
COC(=O)[C@@H](N1CCc2sccc2C1)c1ccccc1Cl
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C16H16ClNO2S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14/h2-5,7,9,15H,6,8,10H2,1H3/t15-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
GKTWGGQPFAXNFI-HNNXBMFYSA-N
|
||||||||||||||||||
| CAS |
113665-84-2
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT06109, Geminin
Protein ID: PT02186, Liver carboxylesterase 1
Clinical Information about the Compound
Drug 1 ( Clopidogrel )
| Drug Name | Clopidogrel | ||
|---|---|---|---|
| Company | Prism Pharmaceuticals Inc | ||
| Indication | |||
| Target(s) |
P2Y purinoceptor 12 (P2RY12)
Antagonist
|
||